82 related articles for article (PubMed ID: 2117333)
21. Results of the multilateral study of Tri-Regol tablet.
Seregély G
Ther Hung; 1991; 39(3):136-41. PubMed ID: 1840164
[TBL] [Abstract][Full Text] [Related]
22. [Our experience in using the triphasic contraceptive trisiston for contraception].
Vasilev D; Katsarova M; Dikov I
Akush Ginekol (Sofiia); 1989; 28(3):63-6. PubMed ID: 2802085
[TBL] [Abstract][Full Text] [Related]
23. [Clinical and biochemical results during the treatment with marvelon, a new oral contraceptive (author's transl)].
Mall-Haefeli M; Werner-Zodrow I; Huber P; Weijers MJ
Geburtshilfe Frauenheilkd; 1982 Mar; 42(3):215-22. PubMed ID: 6210600
[TBL] [Abstract][Full Text] [Related]
24. Clinical and endocrine effects of long-term hormonal contraception.
Balogh A
Acta Med Hung; 1986; 43(2):97-102. PubMed ID: 3588164
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic usefulness of anteovin.
Menyhárt K
Ther Hung; 1989; 37(3):168-71. PubMed ID: 2588200
[TBL] [Abstract][Full Text] [Related]
26. Effect of oral contraceptive (ethinyl estradiol and d-norgestrel) on serum prolactin-oestradiol and progesterone levels.
Erodogan M; Inal A; Ozgu M; Beksac MS; Ergurbuz I
Acta Reprod Turc; 1980 Jan; 1(3):85-91. PubMed ID: 12262090
[TBL] [Abstract][Full Text] [Related]
27. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
28. Influence of oral contraceptives on immediate postabortal pituitary-ovarian function.
Lähteenmäki P
Acta Obstet Gynecol Scand Suppl; 1978; 76():1-43. PubMed ID: 696249
[No Abstract] [Full Text] [Related]
29. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
[TBL] [Abstract][Full Text] [Related]
30. [Our experience in using the Hungarian biphasic systemic contraceptive anteovin].
Vasilev D; Katsarova M
Akush Ginekol (Sofiia); 1990; 29(2):78-81. PubMed ID: 2400066
[No Abstract] [Full Text] [Related]
31. [A clinical study of the triphasic contraceptive Tri-Regol].
Rachev E
Akush Ginekol (Sofiia); 1995; 34(2):64-5. PubMed ID: 8651433
[No Abstract] [Full Text] [Related]
32. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of ovulation by a new low-dose monophasic contraceptive containing gestodene.
Thomas KH; Vankrieken L
Int J Fertil; 1989 Sep; 34 Suppl():10-21. PubMed ID: 2576249
[TBL] [Abstract][Full Text] [Related]
34. The effect of ampicillin on oral contraceptive effectiveness.
Friedman CI; Huneke AL; Kim MH; Powell J
Obstet Gynecol; 1980 Jan; 55(1):33-7. PubMed ID: 7188714
[TBL] [Abstract][Full Text] [Related]
35. Observations with Anteovin in relation to age.
Szigethy A
Ther Hung; 1991; 39(1):11-5. PubMed ID: 1858069
[TBL] [Abstract][Full Text] [Related]
36. Experience with hormonal contraceptives.
Kulakov VI
Acta Med Hung; 1986; 43(2):93-6. PubMed ID: 3588163
[TBL] [Abstract][Full Text] [Related]
37. [Serum prolactin levels in women using oral contraceptives (Gravistat)].
Mikrut W; Jeske W
Ginekol Pol; 1985 Oct; 56(10):620-3. PubMed ID: 4092990
[No Abstract] [Full Text] [Related]
38. Oral contraception with a biphasic tablet (observations with anteovin).
Tallián F
Ther Hung; 1986; 34(2):112-6. PubMed ID: 3449970
[No Abstract] [Full Text] [Related]
39. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
[TBL] [Abstract][Full Text] [Related]
40. Effects of exogenous steroids on gonadotrophin secretion.
Johansson ED
Clin Obstet Gynaecol; 1976 Dec; 3(3):579-90. PubMed ID: 1009733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
